AI Terminal
Azelis Group NV
Major Shareholding Notification • Nov 18, 2025
3909_mrq_2025-11-18_da5f2ae7-503b-496b-b259-c9a2dffd7d88.pdf
Major Shareholding Notification
Open in ViewerOpens in native device viewer
Azelis news release REGULATED INFORMATION
18 November 2025
Transparency notification from EQT VIII Fund
Antwerp (Belgium), 18 November 2025 – 17:46 CET – In accordance with Article 14 of the Belgian Transparency law of May 2, 2007, Azelis Group NV announces that it has received a transparency notification from EQT VIII Fund.
1. Summary of the notification
EQT VIII Fund reported in its notification dated 14 November 2025, that on 12 November 2025, following a disposal of voting securities, its participation decreased and crossed downwards the threshold of 10.00% in Azelis Group NV.
On 12 November 2025, EQT VIII Fund (taking into account the holding of its affiliates) owned 24,226,853 shares with voting rights, representing 9.93% of the total number of shares issued by the company (243,921,719), versus 68,119,809 shares representing 27.93% in its previous notification dated 28 February 2025.
2. Content of the notification
Reason for the notification
Acquisition or disposal of voting securities or voting rights
Notification by
A parent undertaking or a controlling person
Persons subject to the notification requirement
| Name | Address (for legal entities) | ||
|---|---|---|---|
| EQT VIII Collect SCSp | 51A Boulevard Royal, 2449 Luxembourg - Luxembourg | ||
| EQT VIII SCSp | 51A Boulevard Royal, 2449 Luxembourg - Luxembourg | ||
| EQT VIII Investments S. à r. l. | 51A Boulevard Royal, 2449 Luxembourg - Luxembourg | ||
| Akita I S. à r. l. | 51A Boulevard Royal, 2449 Luxembourg - Luxembourg |
Date on which the threshold is crossed
12 November 2025
Threshold that is crossed (in %)
10%
Denominator
243,921,719
Notified Details
| A) Voting rights | Previous notification |
After the transaction | |||
|---|---|---|---|---|---|
| # of voting rights | # of voting rights | % of voting rights | |||
| Holders of voting rights | Linked to securities | Not linked to the securities | Linked to securities |
Not linked to the securities | |
| EQT VIII Collect SCSp | 0 | 0 | 0 | 0.00% | |
| EQT VIII SCSp | 0 | 0 | 0 | 0.00% | |
| EQT VIII Investments S. à r. l. |
0 | 0 | 0 | 0.00% | |
| Akita I S. à r. l. | 68,119,809 | 24,226,853 | 0 | 9.93% | |
| Subtotal | 68,119,809 | 24,226,853 | 0 | 9.93% | |
| TOTAL | 24,226,853 | 0 | 9.93% |
| B) Equivalent financial instruments | After the transaction | |||||
|---|---|---|---|---|---|---|
| Holders of equivalent financial instruments |
Type of financial instrument |
Expiration date |
Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights |
Settlement |
| 0 | 0.00% | |||||
| TOTAL | 0 | 0.00% |
| TOTAL (A & B) | # of voting rights | % of voting rights |
|
|---|---|---|---|
| CALCULATE | 24,226,853 | 9.93% |
Chain of controlled undertakings through which the holding is effectively held, if applicable
Akita I S. à r. l. is controlled by EQT VIII Investments S. à r. l. that is controlled by EQT VIII SCSp. EQT VIII SCSp is controlled by EQT VIII Collect SCSp. EQT VIII Collect SCSp is not controlled by any of its shareholders. EQT VIII Collect SCSp is managed by EQT Fund Management S.à r.l.
Additional information
Akita I S. à r. L. has sold these shares to JNE Partners, First Pacific Advisors and Temasek, all existing shareholders of Azelis Group NV, and others. As certain parts of the transaction settled on 14 November 2025, the notified details under section 10 reflect the situation as of 14 November 2025. However, the threshold was crossed on 12 November 2025.
3. Further information
The full transparency notification as well as this press release can be consulted on the Azelis Group NV's website.
Contact information:
Azelis
About Azelis
Azelis is a leading global innovation service provider in the speciality chemical and food ingredients industry present in 65 countries across the globe with over 4,300 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to more than 62,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.2 billion (2024). Azelis Group NV is listed on Euronext Brussels under ticker AZE.
Across our extensive network of more than 70 application laboratories, our award-winning teams help develop formulations and provide technical guidance throughout the customers' product development process. We combine a global market reach with a local footprint to offer a reliable, integrated, and unique digital service to local customers and attractive- business opportunities to principals. Top industry-rated by Sustainalytics, Azelis is a leader in sustainability. We believe in building and nurturing solid, honest, and transparent relationships with our people and partners.
Impact through ideas. Innovation through formulation.
